Group 1D: Early-Stage Breast Cancer; ER+; Risk of Recurrence

Poster #P2-10-07: Practice patterns and survival analysis of early-stage HER2-negative breast cancers with low and intermediate levels of hormone receptor expression: a 2018-2020 US National Cancer Database analysis

Poster #P4-01-26: The Xpert® Breast Cancer Insight test predicts distant recurrence and overall survival in estrogen receptor-positive, HER2-negative early breast cancer: A validation study in ABCSG Trial 8